Blood Pressure Goal of 140 to 150 mm Hg Is Best for Patients with Diabetes
Am Fam Physician. 2016 Jul 1;94(1):59a-60.
What is the appropriate antihypertensive treatment goal for patients with diabetes mellitus?
Although most recent practice guidelines have relaxed the blood pressure goals for patients with diabetes, there are still a few holdouts that suggest aggressive treatment. This analysis shows that the ideal range for hypertension control in patients with diabetes is between 140 and 150 mm Hg; higher or lower sustained blood pressures increase mortality, the so-called J-curve. (Level of Evidence = 1a)
These researchers searched four databases, including the Cochrane Central library, identifying 49 studies enrolling 73,738 participants with (mostly type 2) diabetes who were treated for hypertension. Two authors independently selected articles for inclusion and extracted data. Heterogeneity and publication bias were assessed but not reported. Most studies were at low risk of bias. The studies evaluated the effect of hypertension treatment on mortality and cardiovascular events but were not specifically designed to compare benefit across different target systolic blood pressures. So, the authors got creative and looked at mortality rates based on baseline (before treatment) and attained (after treatment) systolic blood pressure. In patients with a baseline blood pressure greater than 140 mm Hg or greater than 150 mm Hg, treatment decreased all-cause mortality on average, though not by much (relative risk [RR] = 0.87; 95% confidence interval [CI], 0.78 to 0.98 and RR = 0.89; 95% CI, 0.80 to 0.99). However, cardiovascular mortality, myocardial infarction risk, and development of end-stage renal disease were decreased by 15% to 25%. If baseline blood pressure was less than 140 mm Hg, however, further treatment did not decrease all-cause mortality and significantly increased the risk of cardiovascular mortality (RR = 1.15; 95% CI, 1.00 to 1.32). These results are somewhat at variance with a meta-analysis published last year that found a reduced risk of stroke and albuminuria with treatment (JAMA. 2015;313(6):603–615).
Study design: Meta-analysis (randomized controlled trials)
Funding source: Government
Setting: Various (meta-analysis)
Reference: Brunström M, Carlberg B. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ. 2016;352:i717.
POEMs (patient-oriented evidence that matters) are provided by EssentialEvidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, please see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.
For definitions of levels of evidence used in POEMs, see http://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.
To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.
This series is coordinated by Sumi Sexton, MD, Associate Deputy Editor.
A collection of POEMs published in AFP is available at https://www.aafp.org/afp/poems.
Want to use this article elsewhere? Get Permissions
More in AFP
MOST RECENT ISSUE
Oct 15, 2020
Access the latest issue of American Family Physician